Document is current
Any future updates will be listed below
-
Authors
Yu, Eun Young
Zahid, Syed S.
Aloe, Sarah
Falck-Pedersen, Erik
Zhou, Xi Kathy
Cheung, Nai-Kong V.
Lue, Neal F. https://orcid.org/0000-0001-9700-6895
-
Funding
Funding for this research was provided by:
Cornell University (N/A, N/A, N/A)
U.S. Department of Health & Human Services | National Institutes of Health (1UL1 TR002384-01)
Williams Randolph Hearst Foundation
- License Information
-
More Information
Article History
Received: 26 April 2021
Accepted: 29 October 2021
First Online: 19 November 2021
Competing interests
: The authors declare the following competing interests: N.K.C. and MSKCC have financial interest in Y-mAbs, Abpro-Labs and Eureka Therapeutics. N.K.C. reports receiving commercial research grants from Y-mabs Therapeutics and Abpro-Labs Inc. N.K.C. was named as inventor on multiple patents filed by MSKCC, including those licensed to Ymabs Therapeutics, Biotec Pharmacon, and Abpro-labs. N.K.C. is a SAB member for Abpro-Labs and Eureka Therapeutics. Link to COI at MSKCC: . All other authors declare no competing interests.
